Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study

被引：0
|
作者：
Kija Shah-Hosseini
Eva-Maria Krudewig
Meike Hadler
Efstrathios Karagiannis
Ralph Mösges
机构：
[1] University of Cologne,Institute of Medical Statistics, Informatics and Epidemiology, Faculty of Medicine
[2] Stallergenes GmbH,undefined
来源：
Advances in Therapy | 2017年 / 34卷
关键词：
Allergic asthma; Allergic rhinoconjunctivitis; Allergy; Grass pollen tablets; Polyallergic; Sublingual immunotherapy (SLIT);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1382 / 1397
页数：15
相关论文
共 50 条
  • [21] Safety Review of 5-Grass Pollen Tablet from Pooled Data of Clinical Trials
    Casale, Thomas B.
    Cox, Linda S.
    Wahn, Ulrich
    Golden, David B. K.
    Bons, Brigitte
    Didier, Alain
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1717 - +
  • [22] Long-term clinical efficacy of a 5-grass pollen sublingual immunotherapy tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Montagut, A.
    Galvain, S.
    Rodriguez, P.
    Malling, H.
    ALLERGY, 2011, 66 : 654 - 654
  • [23] Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy
    Valovirta, Erkka
    Petersen, Thomas H.
    Piotrowska, Teresa
    Laursen, Mette K.
    Andersen, Jens S.
    Sorensen, Helle F.
    Klink, Rabih
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : 529 - +
  • [24] SAFETY OF THE 5-GRASS POLLEN SUBLINGUAL TABLET IN MONO- AND POLY-SENSITIZED PATIENTS WITH GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS.
    Golden, D. B.
    Abiteboul, K.
    Zeldin, R. K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A99 - A99
  • [25] Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis
    Zeldin, Robert K.
    Amistani, Yann
    Cognet-Sice, Josiane
    Abiteboul, Kathy
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [26] Long-term compliance with the 300IR 5-grass pollen sublingual tablet in subjects with grass pollen-induced allergic rhinoconjunctivitis
    Zeldin, R. K.
    Cognet-Sice, J.
    Paolozzi, L.
    ALLERGY, 2015, 70 : 377 - 378
  • [27] Sustained and post-treatment efficacy of a 5-grass pollen allergen extract sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
    Zeldin, R. K.
    Melac, M.
    Amistani, Y.
    Didier, A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (03) : 298 - 298
  • [28] Impact of sublingual immunotherapy with a five-grass pollen tablet on grass pollen allergic rhinitis and asthma: A real-life, long-term analysis in France
    Demoly, P.
    Devillier, P.
    Ansolabehere, X.
    Bardoulat, I
    Molimard, M.
    ALLERGY, 2018, 73 : 618 - 619
  • [29] Budget impact model of a 5-grass sublingual immunotherapy tablet for the treatment of grass pollen-induced allergic rhinitis
    Ivanova, Jasmina I.
    Kelkar, Sneha
    King, Sarah
    Birnbaum, Howard G.
    Hocker, Sue
    Phipps, Robert
    Lankow, Richard
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (11) : 909 - 918
  • [30] Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review
    Didier, Alain
    Bons, Brigitte
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 777 - 788
12345